Chaim Lebovits, President & CEO at BRAINSTORM CELL THERAPEUTICS INC. (BCLI), bought 23,836 shares at $3.43 ($11K) on 2024-10-01, disclosed to the SEC on 2024-10-02.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.23 | 22,000 | $5K | 44.6% |
| 2 | $3.43 | 1,836 | $6K | 55.4% |
| Total | $0.48 avg | 23,836 | $11K | 100% |
| Filing → |